SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-033910
Filing Date
2021-06-23
Accepted
2021-06-23 08:35:53
Documents
4
Period of Report
2021-06-23

Document Format Files

Seq Description Document Type Size
1 6-K lmnl-6k_20210622.htm 6-K 23755
2 EX-99.1 lmnl-ex991_6.htm EX-99.1 19192
3 GRAPHIC g2tquhwfuz5i000001.jpg GRAPHIC 38195
4 GRAPHIC g43umd3eyihv000001.jpg GRAPHIC 2579
  Complete submission text file 0001564590-21-033910.txt   100503
Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4
Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 450-781-0115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39131 | Film No.: 211037260
SIC: 2834 Pharmaceutical Preparations